"Leica" Bond Ready-to-Use Primary Antibody Cytokeratin 20 (Ks20.8) (Non-Sterile) - Taiwan Registration 698d4fe8a3b1eaffe9ff180936557fc9

Access comprehensive regulatory information for "Leica" Bond Ready-to-Use Primary Antibody Cytokeratin 20 (Ks20.8) (Non-Sterile) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 698d4fe8a3b1eaffe9ff180936557fc9 and manufactured by LEICA BIOSYSTEMS NEWCASTLE LTD.. The authorized representative in Taiwan is BECKMAN COULTER TAIWAN INC., TAIWAN BRANCH (U.S.A.).

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.